Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-03.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma
Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Pathol Transl Med > Volume 46(6); 2012 > Article
Case Report
Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma
Sung Eun Kim,, Ji Hye Park, SoonWon Hong, Ja Seung Koo, Joon Jeong1, Woo-Hee Jung
Korean Journal of Pathology 2012;46(6):611-616.
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.6.611
Published online: December 26, 2012

Department of Pathology, Gangnam Sevrance Hsopital, Yonsei University College of Medicine, Seoul, Korea.

1Department of Surgery, Gangnam Sevrance Hsopital, Yonsei University College of Medicine, Seoul, Korea.

Corresponding Author: Woo-Hee Jung, M.D. Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Korea. Tel: +82-2-2019-3541, Fax: +82-2-3463-2103, 'Jungwh96@yuhs.ac'
*Sung Eun Kim's present address: Department of Pathology, Cha Gangnam Medical Center, Cha University, Seoul, Korea.
• Received: April 10, 2012   • Revised: July 2, 2012   • Accepted: July 17, 2012

© 2012 The Korean Society of Pathologists/The Korean Society for Cytopathology

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 7,177 Views
  • 48 Download
  • 12 Crossref
  • 17 Scopus
  • Mucinous cystadenocarcinoma (MCA) in the breast is a rare neoplasm. There have been 13 cases of primary breast MCA reported. The MCA presents as a large, partially cystic mass in postmenopausal woman with a good prognosis. The microscopic findings resemble those of ovarian, pancreatic, or appendiceal MCA. The aspiration findings showed mucin-containing cell clusters in the background of mucin and necrotic material. The cell clusters had intracytoplasmic mucin displacing atypical nuclei to the periphery. Histologically, the tumor revealed an abundant mucin pool with small floating clusters of mucin-containing tumor cells. There were also small cysts lined by a single layer of tall columnar mucinous cells, resembling those of the uterine endocervix. The cancer cells were positive for mucin (MUC) 5 and negative for MUC2 and MUC6. This mucin profile is different from ordinary mucinous carcinoma and may be a unique characteristic of breast MCA.
The primary mucinous cystadenocarcinoma (MCA) of the breast is an extremely rare neoplasm. The most common sites of MCA include the ovary, pancreas and appendix. Only 13 cases of primary MCA of the breast have been reported, since Koenig and Tavassoli reported the first 4 cases of MCA in 1998 (Tables 1, 2).1-10 The breast MCAs showed unique clinico-pathologic characteristics, distinguishable from ordinary mucinous carcinoma (MC) and signet ring cell carcinoma. Clinically, MCA in the breast is found in postmenopausal women and present as a relatively large, cystic mass with a favorable prognosis. Microscopically, the cysts are lined by tall columnar mucinous cells, resembling those of endocervical glands. The MCA tumors demonstrate consistent immunohistochemical staining (IHC) results with negative estrogen receptor (ER), negative progesterone receptor (PR), positive cytokeratin 7 (CK7), and negative cytokeratin 20 (CK20). The c-erbB2 IHC results are available in five cases.4,5,7-9 They are negative in four and positive in one with HER-2 gene amplification confirmed by fluorescence in situ hybridization.9
In the case being reported here, the mass was only 9 mm, though the size before core biopsy was assessed to be 14 mm by ultrasound examination. Other characteristics of this new case share those clinical, cytological, and histopathological findings described in previously published cases (Tables 1, 2). In this paper, we present a rare cytologic finding of primary MCA in the breast and the characteristics of mucin (MUC).
Clinical summary
A 59-year-old postmenopausal woman presented with an illdefined, hard mass in her left breast for a year. Radiologic evaluations demonstrated a hypo-echoic mass (14 mm) with a speculated margin in ultrasonography and a focal asymmetric density in the upper medial portion by mammography. Fine needle aspiration followed by needle biopsy was performed with the diagnosis of MC and invasive carcinoma with abundant mucin pool formation, respectively. She underwent partial mastectomy with sentinel lymph node biopsy. The sentinel lymph node was free from metastasis. She has been followed for 3 months with chemotherapy for adjuvant treatment and remains disease-free.
Pathologic findings
The aspiration showed a few scattered, variably sized, irregular clusters of columnar cells in the greenish blue mucinous background with necrotic debris. The columnar cells contained abundant mucin vacuoles in cytoplasm which had displaced their nuclei. The nuclear membrane was irregular and sharply angulated and the nuclei revealed a coarse chromatin pattern with prominent nucleoli (Fig. 1).
On gross examination, the cut surface showed an irregular, white to tan, solid and firm mass (9×7 mm), with a glistening appearance. Most MCAs in previous reports have demonstrated grossly cystic cut surfaces, except one case of MCA reported from Koenig and Tavassoli2 in 1998.1,3-10 The case in 1998 was small in size (8 mm) and had a grossly solid appearance. The present case was 9 mm in maximal diameter and did not contain a macroscopic cyst. It is assumed that the small size of the MCA meant that it did not produce enough mucin to fill out and dilate cysts and ductal structures. The microscopic findings revealed a few cysts and ductal carcinoma in situ, adjacent to the invasive carcinoma. The cysts were lined by a single layer of tall columnar mucinous cells with focal areas of micropapillary structures, resembling those of the uterine endocervix. The luminal space contained mucin (Fig. 2). The invasive cancer area contained an abundant mucin pool in stroma with floating cell clusters. The floating cells contained mucin vacuoles in cytoplasm displacing atypical nuclei to the periphery.
Special staining and IHC on paraffin embedded tissue were performed. Both intracytoplasmic and extracytoplasmic mucin were stained by periodic acid-Schiff with diastase, alcian blue and mucicarcine, representing the acidic and neutral nature of mucin. The tumor cells were positive for CK7 and negative for CK20 and CDX-2. The IHC for MUC proteins was performed. The cancer cells were positive for MUC5 and MUC1 and negative for MUC2 and MUC6. Mucin of the intracytoplasm and stroma revealed positivity for MUC5 and negativity for the other MUC proteins (MUC1, MUC2, and MUC6). The hormone receptors, ER and PR, were negative. The c-erbB2 was 2-positive (Fig. 3), but silver in situ hybridization demonstrated no amplification of the HER-2 gene.
In the breasts, mucin-producing tumors are classified as MC, signet ring cell carcinoma (SRC), or mucocele-like tumors.11 The differences among mucin-containing tumors in the breast are shown in Table 3.12-14 MC and mucocele-like tumors are characterized by abundant extracellular mucin with floating neoplastic cells that do not contain intracytoplasmic mucin. The mucocele-like tumor is benign and the floating tumor cells are very rare. MC is specific type of invasive ductal caricinoma. The cytologic features show tight clusters of bland looking cells with moderate cellularity in the mucinous background.13 SRC demonstrates mucin only in the cytoplasm. The aspiration reveals a cellular smear of pleomorphic and plasmocytoid cells with intracytoplasmic mucin in the bloody or necrotic background.14 MCA has similar characteristics to both MC and SRC. The aspiration smears reveal tight clusters of mucin-containing cells of low to moderate cellularity in the background of mucinous and necrotic material. The histopathologic findings confirm both, intracytoplasmic and extracytoplasmic mucin.
Mucin is a high molecular weight glycoprotein that consists of one protein core and O-linked carbohydrate side chains attached.15 Epithelial cells produce two types of mucin. One is secretory mucin (MUC2, MUC5, and MUC6) and the other is trans-membrane mucin (MUC1, MUC3, MCU4, MUC12, and MUC17).16 They are expressed differently according to the types of organs and tumors. For example, MC of the colon shows high positivity for MUC2.17 SRC of the colon shows MUC2 and MUC4 positivity.16 Among breast cancers, MC expresses mainly MUC2 along with a low level of MUC1, while SRC of the breast has a high level of MUC1 expression with a variable level of MUC2.18 In the breasts, MUC5 is not frequently observed. MCs of the breast express MUC5 in only small proportions (less than 5%).19 In our case of MCA reported here, the MUC IHC demonstrates a high level of expression of MUC5 and no expression of MUC2 or MUC6. This mucin profile is different from ordinary mucinous carcinoma arising in the breast and other organs. MUC5-positive and MUC2-negative immunoprofiles have not been reported before, in breast carcinoma.
Because of the rarity of mammary MCA, the diagnosis has to be made cautiously. Thus metastasis from distant organs should be initially considered. The usual immunoprofiles to rule out metastasis from distant MCA are following: CK7 positive, CK20 negative, and CDX-2 negative. These results can help to exclude the possibility of metastatic MCA from the ovary, pancreas, and gastrointestinal tract. Being MUC5 positive and MUC2 negative may be the unique characteristics of MCA in the breast, together with the immunoprofiles of being CK7 positive, CK20 negative, CDX-2 negative, ER negative, and PR negative.

No potential conflict of interest relevant to this article was reported.

  • 1. Rosen PP, Scott M. Cystic hypersecretory duct carcinoma of the breast. Am J Surg Pathol 1984; 8: 31–41. PMID: 6320685. ArticlePubMed
  • 2. Koenig C, Tavassoli FA. Mucinous cystadenocarcinoma of the breast. Am J Surg Pathol 1998; 22: 698–703. PMID: 9630176. ArticlePubMed
  • 3. Domoto H, Terahata S, Yamazaki T, Sato K, Takeo H, Tamai S. Mucinous cystadenocarcinoma of the breast showing sulfomucin production. Histopathology 2000; 36: 567–569. PMID: 10849102. ArticlePubMed
  • 4. Honma N, Sakamoto G, Ikenaga M, Kuroiwa K, Younes M, Takubo K. Mucinous cystadenocarcinoma of the breast: a case report and review of the literature. Arch Pathol Lab Med 2003; 127: 1031–1033. PMID: 12873181. ArticlePubMed
  • 5. Chen WY, Chen CS, Chen HC, Hung YJ, Chu JS. Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinoma. Pathol Int 2004; 54: 781–786. PMID: 15482568. ArticlePubMed
  • 6. Coyne JD, Irion L. Mammary mucinous cystadenocarcinoma. Histopathology 2006; 49: 659–660. PMID: 17163855. ArticlePubMed
  • 7. Lee SH, Chaung CR. Mucinous metaplasia of breast carcinoma with macrocystic transformation resembling ovarian mucinous cystadenocarcinoma in a case of synchronous bilateral infiltrating ductal carcinoma. Pathol Int 2008; 58: 601–605. PMID: 18801076. ArticlePubMed
  • 8. Rakici S, Gönüllü G, Gürsel SB, Yildiz L, Bayrak IK, Yücel I. Mucinous cystadenocarcinoma of the breast with estrogen receptor expression: a case report and review of the literature. Case Rep Oncol 2009; 2: 210–216. PMID: 20737039. ArticlePubMedPMC
  • 9. Petersson F, Pang B, Thamboo TP, Putti TC. Mucinous cystadenocarcinoma of the breast with amplification of the HER2-gene confirmed by FISH: The first case reported. Hum Pathol 2010; 41: 910–913. PMID: 20338619. ArticlePubMed
  • 10. Sentani K, Tashiro T, Uraoka N, et al. Primary mammary mucinous cystadenocarcinoma: cytological and histological findings. Diagn Cytopathol 2012; 40: 624–628. PMID: 21472867. ArticlePubMed
  • 11. Rosen PP. Rosen's breast pathology. 2009; 3rd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 515–534.
  • 12. Cheng L, Lee WY, Chang TW. Benign mucocele-like lesion of the breast: how to differentiate from mucinous carcinoma before surgery. Cytopathology 2004; 15: 104–108. PMID: 15056171. ArticlePubMed
  • 13. Laucirica R, Bentz JS, Khalbuss WE, Clayton AC, Souers RJ, Moriarty AT. Performance characteristics of mucinous (colloid) carcinoma of the breast in fine-needle aspirates: observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology. Arch Pathol Lab Med 2011; 135: 1533–1538. PMID: 22129179. ArticlePubMed
  • 14. Kelten C, Akbulut M, Zekioglu O, Kapkac M, Erhan Y, Ozdemir N. Signet ring cells in fine needle aspiration cytology of breast carcinomas: review of the cytological findings in ten cases identified by histology. Cytopathology 2009; 20: 321–327. PMID: 19284410. ArticlePubMed
  • 15. Lau SK, Weiss LM, Chu PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol 2004; 122: 61–69. PMID: 15272531. ArticlePubMed
  • 16. Nguyen MD, Plasil B, Wen P, Frankel WL. Mucin profiles in signet-ring cell carcinoma. Arch Pathol Lab Med 2006; 130: 799–804. PMID: 16740030. ArticlePubMed
  • 17. Chu PG, Chung L, Weiss LM, Lau SK. Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases. Am J Surg Pathol 2011; 35: 1830–1836. PMID: 21881489. ArticlePubMed
  • 18. Hanski C, Hofmeier M, Schmitt-Gräff A, et al. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol 1997; 182: 385–391. PMID: 9306958. ArticlePubMed
  • 19. Matsukita S, Nomoto M, Kitajima S, et al. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Histopathology 2003; 42: 26–36. PMID: 12493022. ArticlePubMed
Fig. 1
Cytologic features of mucinous cystadenocarcinoma. (A) A few scattered, variably sized, irregular clusters of columnar cells with pleomorphism and anisocytosis in a greenish blue mucinous background and necrotic debris. (B) The cells contain abundant mucin vacuoles in cytoplasm that attenuate and displace their nuclei. The nuclear membrane is irregular and sharply angulated and the nuclei reveal a coarse chromatin pattern with prominent nucleoli.
kjpathol-46-611-g001.jpg
Fig. 2
Histologic features of mucinous cystadenocarcinoma. (A) The tumor shows an abundant mucin pool in stroma with floating cell clusters. (B) The ductal carcinoma in situ is found in the form of small cysts, adjacent to the invasive carcinoma. The cysts are lined by a single layer of tall columnar mucinous cells with focal areas of micropapillary and small tufted structures, resembling those of the uterine endocervix. (C) The invasive cells are pleomorphic and contained mucin vacuoles in cytoplasm displacing atypical nuclei to the periphery. (D) Both the intracytoplasmic and extracytoplasmic mucin are stained by alcian blue.
kjpathol-46-611-g002.jpg
Fig. 3
Immunohistochemical staining of mucinous cystadenocarcinoma. The tumor cells are positive for cytekeratin 7 (A) and negative for cytokeratin 20 (B). The hormone receptors, estrogen receptor and progesterone receptor, are negative and the c-erbB2 is 2-positive (C). The tumor cells are positive for mucin (MUC) 1 (D) along the cytoplasmic membrane and negative for MUC2 (E). Mucin of the intracytoplasm and stroma reveal positivity for MUC5 (F).
kjpathol-46-611-g003.jpg
Table 1
Clinical feature of mucinous cystadenocarcinoma in the breast
kjpathol-46-611-i001.jpg

TNM, tumor-node-metastasis; N/A, not acquired; MRM, modified radical mastectomy; c LND, with lymph node dissection; Chm+RT, chromatography+radiation therapy; PM, partial mastectomy.

Table 2
Immunohistochemical feature of mucinous cystadenocarcinoma in the breast
kjpathol-46-611-i002.jpg

ER, estrogen receptor; PR, progesterone receptor; CK7, cytokeratin 7; CK20, cytokeratin 20; N, negative; P, positive.

Table 3
Comparison of mucin-producing tumors in the breast
kjpathol-46-611-i003.jpg

MCA, mucinous cystadenocarcinoma; N/A, not availale; ADH, atypical ductal hyperplasia; DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; ILC, infiltrating lobular carcinoma.

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Mucinous cystadenocarcinoma of the breast harbours TRPS1 expressions and PIK3CA alterations
      Wei‐Yu Chen, Yu‐Hsuan Hu, Yu‐Hsin Tsai, Jen‐Fan Hang, Puay Hoon Tan, Chih‐Jung Chen
      Histopathology.2024; 84(3): 550.     CrossRef
    • Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
      Yash Hasmukhbhai Prajapati, Vishal Bhabhor, Kahan Samirkumar Mehta, Mithoon Barot, Husen Boriwala, Mohamed Omar
      Clinical Case Reports.2024;[Epub]     CrossRef
    • Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review
      Ting Lei, Yong Qiang Shi, Tong Bing Chen
      Diagnostic Pathology.2023;[Epub]     CrossRef
    • Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association
      Federica Vegni, Nicoletta D’Alessandris, Angela Santoro, Giuseppe Angelico, Giulia Scaglione, Angela Carlino, Damiano Arciuolo, Michele Valente, Stefania Sfregola, Maria Natale, Alejandro Martin Sanchez, Valeria Masciullo, Gian Franco Zannoni, Antonino Mu
      Journal of Personalized Medicine.2023; 13(6): 948.     CrossRef
    • Special Histologic Type and Rare Breast Tumors – Diagnostic Review and Clinico-Pathological Implications
      Benjamin Yongcheng Tan, Elaine Hsuen Lim, Puay Hoon Tan
      Surgical Pathology Clinics.2022; 15(1): 29.     CrossRef
    • Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials—a case report
      Kanwalpreet Kaur, Ashini Shah, Jahnvi Gandhi, Priti Trivedi
      Journal of the Egyptian National Cancer Institute.2022;[Epub]     CrossRef
    • Mucinous carcinoma of the breast: distinctive histopathologic and genetic characteristics
      Minjung Jung
      Kosin Medical Journal.2022; 37(3): 176.     CrossRef
    • Primary Mucinous Cystadenocarcinoma of the Breast: A Rare Case Report With Review of Literature
      Ekta Jain, Abhishek Kumar, Raajul Jain, Shivani Sharma
      International Journal of Surgical Pathology.2021; 29(7): 740.     CrossRef
    • Mucinous Cystadenocarcinoma of the Breast: Report of 2 Cases Including One With Long-Term Local Recurrence
      Anupma Nayak, Ira J. Bleiweiss, Kimberly Dumoff, Tawfiqul A. Bhuiya
      International Journal of Surgical Pathology.2018; 26(8): 749.     CrossRef
    • Mucinous breast carcinoma with tall columnar cells
      N Tsoukalas, M Kiakou, M Tolia, ID Kostakis, M Galanopoulos, G Nakos, D Tryfonopoulos, G Kyrgias, G Koumakis
      The Annals of The Royal College of Surgeons of England.2018; 100(5): e132.     CrossRef
    • Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review
      Minjung Seong, Eun Young Ko, Boo-Kyung Han, Soo Youn Cho, Eun Yoon Cho, Se Kyung Lee, Jeong Eon Lee
      Journal of Breast Cancer.2016; 19(3): 330.     CrossRef
    • Primary Mucinous Cystadenocarcinoma of the Breast with Endocervical-Like Mucinous Epithelium
      Dong-Liang Lin, Ji-Lin Hu, Shi-Hong Shao, Dong-Mei Sun, Ji-Gang Wang
      Breast Care.2013; 8(6): 445.     CrossRef

    • PubReader PubReader
    • Cite this Article
      Cite this Article
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma
      Korean J Pathol. 2012;46(6):611-616.   Published online December 26, 2012
      Close
    • XML DownloadXML Download
    Figure
    Related articles

    J Pathol Transl Med : Journal of Pathology and Translational Medicine